Clinical Trial Update: Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above [Phase 2]

View source ↗

Summary

Phase II clinical trial update for a lyophilized mRNA vaccine targeting respiratory syncytial virus in adults aged 50 years or older. The study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Lyophilized RSV mRNA vaccine (Respiratory syncytial virus mRNA vaccine)

Snippet

Sponsor: Suzhou Abogen Biosciences Co., Ltd. | Conditions: Respiratory Syncytial Virus | Phase 2 | Status: ACTIVE_NOT_RECRUITING